T-cell trafficking can be impaired by tumor-vascular structure52, aberrant tumor extracellular-matrix architecture53, presence of myeloid-derived suppressor cells (MDSCs)54, hypoxia55, lack of T-cell recruitment-associated chemokines such as CCL5 and CXCL956, as well as other mechanisms. This evidence concerns the gene CCL5 and neoplasm.